Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIa

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8455627
APP PUB NO 20110165175A1
SERIAL NO

12877003

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to an antibody or derivative thereof of human origin for inhibiting platelet aggregation, characterized in that it is effective by substantially exclusive binding to the activated state of platelet integrin receptor GPIIb/IIIa.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AFFIMED THERAPEUTICS AGIM NEUENHEIMER FELD 582 HEIDELBERG 69120

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Knackmuss, Stefan Plankstadt, DE 17 78
Linhard, Claudia Schwetzingen, DE 1 12
Little, Melvyn St. Peter-Ording, DE 36 628
Peter, Karlheinz Hawthorn East, AU 36 108
Roettgen, Peter Ladenburg, DE 4 24
Schwarz, Meike Rastatt, DE 3 23

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 4, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00